Trial Profile
Clinical Trials Insight: 700006565
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs NGX 267 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 31 Oct 2005 New trial record.